This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here

BHC Insider Trading (Bausch Health Companies)

Insider Ownership Percentage: 12.14%
Insider Buying (Last 12 Months): $79,724,762.22
Insider Selling (Last 12 Months): $3,051,259.47

Bausch Health Companies Insider Trading History Chart

Bausch Health Companies Share Price & Price History

▼ -0.52 (-1.65%)
As of 02/24/2021 01:00 AM ET
Days: 30 | 90 | 365
This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here

Bausch Health Companies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2020William D HumphriesInsiderSell114,055$19.87$2,266,272.85349,090  
11/27/2020William D HumphriesInsiderSell13,663$19.63$268,204.69236,518  
11/24/2020William D HumphriesInsiderSell21,658$19.63$425,146.54236,518  
9/8/2020William D HumphriesInsiderSell5,667$16.17$91,635.39235,035  
6/5/2020Holdings L.P. ValueactDirectorBuy948,353$19.24$18,246,311.72  
5/14/2020John PaulsonDirectorBuy1,628,920$15.87$25,850,960.40  
5/12/2020John PaulsonDirectorBuy2,041,036$17.35$35,411,974.60  
3/10/2020Christina AckermannEVPBuy4,390$18.25$80,117.5087,245  
3/10/2020Eschenbach Andrew C VonDirectorBuy1,100$18.18$19,998.0018,565  
3/3/2020Schutter Richard U DeDirectorBuy5,000$23.08$115,400.00279,250  
9/13/2019Joseph C PapaCEOBuy30,000$23.31$699,300.00
8/19/2019Mark C MckennaInsiderSell10,773$21.83$235,174.5920,756  
8/16/2019William D HumphriesInsiderBuy30,703$21.18$650,289.54  
8/12/2019Christina AckermannEVPSell3,418$22.45$76,734.10  
7/11/2019Christina AckermannEVPSell3,968$24.81$98,446.08  
2/28/2019Joseph C PapaCEOBuy30,000$23.67$710,100.00  
12/14/2018Thomas AppioInsiderBuy25,440$22.96$584,102.40  
10/16/2018Christina AckermannEVPSell19,946$24.98$498,251.08  
9/14/2018Joseph C PapaCEOBuy30,000$22.32$669,600.00  
9/14/2018Paul HerendeenCFOBuy10,000$22.61$226,100.00  
9/13/2018Schutter Richard U DeDirectorBuy125,000$23.96$2,995,000.00  
5/15/2018Schutter Richard U DeDirectorBuy10,000$21.80$218,000.00  
5/15/2018Schutter Richard U DeDirectorBuy15,000$21.83$327,450.00  
3/13/2018Joseph C PapaCEOBuy30,000$16.05$481,500.00  
3/13/2018Paul HerendeenCFOBuy15,000$16.10$241,500.00  
3/8/2018Schutter Richard U DeDirectorBuy10,000$15.34$153,400.00106,062  
3/6/2018John PaulsonDirectorBuy7,066,629$15.40$108,826,086.60  
See Full Table

SEC Filings (Institutional Ownership Changes) for Bausch Health Companies (NYSE:BHC)

62.92% of Bausch Health Companies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bausch Health Companies Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/19/2021JPMorgan Chase & Co.1,336,488$27.80M0.0%+5.3%0.376%
2/18/2021Safeguard Investment Advisory Group LLC2,946$61K0.1%N/A0.001%
2/18/2021Truist Financial Corp13,850$0.29M0.0%+3.6%0.004%
2/17/2021IHT Wealth Management LLC12,029$0.25M0.0%-6.3%0.003%
2/17/2021Invenomic Capital Management LP134,695$2.80M0.7%-25.1%0.038%
2/17/2021Canada Pension Plan Investment Board1,143,476$23.73M0.0%+188.2%0.322%
2/16/2021Tokio Marine Asset Management Co. Ltd.16,700$0.35M0.0%+36.9%0.005%
2/16/2021One68 Global Capital LLC13,000$0.27M0.5%-86.1%0.004%
2/16/2021M.D. Sass Investors Services Inc.1,127,868$23.46M5.0%+11.7%0.318%
2/16/2021Brookfield Asset Management Inc.77,058$1.60M0.0%N/A0.022%
2/16/2021Mariner LLC16,628$0.35M0.0%+3.1%0.005%
2/16/2021Morgan Stanley7,527,373$156.57M0.0%-0.7%2.119%
2/16/2021Colony Group LLC138,061$2.87M0.1%-13.4%0.039%
2/16/2021Price T Rowe Associates Inc. MD5,869,861$122.09M0.0%-45.8%1.653%
2/16/2021Poehling Capital Management LLC72,822$1.52M0.6%+21.5%0.021%
2/16/2021Cobalt Capital Management Inc.317,500$6.60M2.3%N/A0.089%
2/16/2021Amundi Pioneer Asset Management Inc.69,391$1.44M0.0%-2.7%0.020%
2/16/2021Centric Wealth Management125,000$2.60M0.8%N/A0.035%
2/16/2021Schroder Investment Management Group661,174$17.46M0.0%+518.6%0.186%
2/16/2021Engineers Gate Manager LP26,867$0.56M0.0%+7.0%0.008%
2/16/2021Avidity Partners Management LP1,972,000$41.02M1.3%N/A0.555%
2/16/2021Janus Henderson Group PLC112,454$2.33M0.0%-30.6%0.032%
2/16/2021Caption Management LLC67,500$1.41M0.0%N/A0.019%
2/13/2021Essex Investment Management Co. LLC38,973$0.81M0.1%-6.7%0.011%
2/13/2021Guardian Capital Advisors LP17,200$0.37M0.1%+88.9%0.005%
2/13/2021Guardian Capital LP5,120,274$106.14M2.5%+40.3%1.442%
2/13/2021PenderFund Capital Management Ltd.318,125$8.40M2.1%-0.3%0.090%
2/12/2021Stifel Financial Corp167,857$3.49M0.0%+0.7%0.047%
2/12/2021Laurion Capital Management LP4,047,765$84.19M0.7%+476.0%1.140%
2/12/2021Beacon Pointe Advisors LLC17,805$0.37M0.0%-12.0%0.005%
2/12/2021Icahn Carl C5,033,147$104.69M0.5%N/A1.417%
2/12/2021Federated Hermes Inc.141,470$2.94M0.0%+1.6%0.040%
2/12/2021qPULA Trading Management LP15,169$0.32M0.6%N/A0.004%
2/12/2021Raymond James Financial Services Advisors Inc.23,261$0.48M0.0%-15.2%0.007%
2/12/2021LPL Financial LLC171,264$3.56M0.0%N/A0.048%
2/12/2021Public Employees Retirement System of Ohio29,555$0.61M0.0%N/A0.008%
2/12/2021The Manufacturers Life Insurance Company 2,260,681$59.70M0.1%+0.1%0.637%
2/12/2021Academy Capital Management Inc. TX861,987$17.93M3.8%+5.1%0.243%
2/12/2021Alpha Paradigm Partners LLC19,188$0.40M0.1%N/A0.005%
2/12/2021Eaton Vance Management42,532$0.89M0.0%-72.1%0.012%
2/12/2021Healthcare of Ontario Pension Plan Trust Fund6,208$0.13M0.0%-95.9%0.002%
2/12/2021Public Sector Pension Investment Board315,943$6.55M0.1%-11.5%0.089%
2/11/2021Longitude Cayman Ltd.220,000$4.58M2.2%N/A0.062%
2/11/2021RBF Capital LLC162,600$3.38M0.3%-19.7%0.046%
2/11/2021Trexquant Investment LP25,455$0.53M0.1%N/A0.007%
2/11/2021Northern Trust Corp333,194$6.93M0.0%+1.7%0.094%
2/11/2021Baird Financial Group Inc.76,766$1.60M0.0%-2.0%0.022%
2/11/2021Scotia Capital Inc.90,144$1.88M0.0%+5.4%0.025%
2/11/2021Handelsbanken Fonder AB69,000$1.44M0.0%+13.9%0.019%
2/11/2021Steward Partners Investment Advisory LLC2,850$59K0.0%-24.0%0.001%
2/11/2021Skandinaviska Enskilda Banken AB publ 1,371,185$22.42M0.2%-2.8%0.386%
2/11/2021Westpac Banking Corp38,286$1.01M0.0%-70.9%0.011%
2/11/2021First Horizon Advisors Inc.5,417$0.11M0.0%+9.1%0.002%
2/11/2021RMB Capital Management LLC75,589$1.57M0.1%-3.1%0.021%
2/11/2021Dynamic Technology Lab Private Ltd12,623$0.26M0.0%N/A0.004%
2/11/2021Oppenheimer Asset Management Inc.56,516$1.18M0.0%+26.7%0.016%
2/11/2021Veriti Management LLC9,113$0.19M0.1%N/A0.003%
2/10/2021Aequim Alternative Investments LP44,800$40K0.0%+244.6%0.013%
2/10/2021Renaissance Technologies LLC1,990,160$41.36M0.0%-45.4%0.560%
2/10/2021Fishman Jay A Ltd. MI31,900$0.66M0.1%-18.8%0.009%
2/10/2021Mackenzie Financial Corp108,981$2.25M0.0%-0.9%0.031%
2/10/2021Clearbridge Investments LLC1,905,962$39.64M0.0%-1.3%0.537%
2/10/2021Boston Partners124,704$2.59M0.0%-8.1%0.035%
2/10/2021HighTower Advisors LLC13,553$0.28M0.0%+17.3%0.004%
2/9/2021Wells Fargo & Company MN1,024,933$21.32M0.0%-22.5%0.289%
2/9/2021Advisory Services Network LLC3,050$63K0.0%-13.8%0.001%
2/9/2021Fiera Capital Corp3,386,290$70.04M0.2%+12.2%0.953%
2/9/2021Van ECK Associates Corp364,192$7.58M0.0%+2.2%0.103%
2/9/2021Bank of New York Mellon Corp508,811$10.58M0.0%-13.6%0.143%
2/9/2021Illinois Municipal Retirement Fund49,649$1.03M0.0%+98.4%0.014%
2/9/2021Blair William & Co. IL66,355$1.38M0.0%+1.2%0.019%
2/9/2021CI Investments Inc.32,400$0.67M0.0%-12.2%0.009%
2/8/2021CIBC World Markets Inc.1,842,918$38.33M0.1%+1.3%0.519%
2/8/2021Fox Run Management L.L.C.12,965$0.27M0.5%N/A0.004%
2/8/2021New York State Common Retirement Fund734,851$15.29M0.0%+13.8%0.207%
2/8/2021Jacobi Capital Management LLC1,850$38K0.0%-48.6%0.001%
2/8/2021FIL Ltd1,502,994$31.18M0.0%+23.4%0.423%
2/5/2021Gamco Investors INC. ET AL775,595$16.13M0.2%+18.0%0.218%
2/5/2021GABELLI & Co INVESTMENT ADVISERS INC.26,000$0.54M0.1%-11.3%0.007%
2/5/2021Gabelli Funds LLC445,000$9.26M0.1%-12.3%0.125%
2/5/2021BlackRock Inc.2,170,941$45.16M0.0%+0.1%0.611%
2/5/2021Aperio Group LLC134,999$2.81M0.0%-40.2%0.038%
2/5/2021Swiss National Bank1,279,960$26.57M0.0%-4.6%0.360%
2/5/2021NEXT Financial Group Inc13,285$0.28M0.0%+18.9%0.004%
2/5/2021Sumitomo Mitsui Trust Holdings Inc.952,340$19.70M0.0%-15.8%0.268%
2/5/2021US Bancorp DE24,175$0.50M0.0%-29.3%0.007%
2/5/2021Intact Investment Management Inc.534,300$14.02M0.5%-16.6%0.150%
2/4/2021Boston Partners124,704$2.59M0.0%-8.1%0.035%
2/4/2021Clear Harbor Asset Management LLC10,800$0.22M0.0%N/A0.003%
2/4/2021Cambridge Investment Research Advisors Inc.10,338$0.22M0.0%-17.5%0.003%
2/4/2021State of Wisconsin Investment Board212,305$4.40M0.0%-7.0%0.060%
2/3/2021Private Management Group Inc.1,090,137$22.68M1.2%-0.6%0.307%
2/3/2021Winslow Evans & Crocker Inc.4,000$83K0.0%+166.7%0.001%
2/3/2021CIBC Asset Management Inc219,014$4.53M0.0%+1.9%0.062%
2/3/2021Financial Sense Advisors Inc.112,700$2.34M0.8%+1.4%0.032%
2/3/2021Ieq Capital LLC375,000$7.80M0.3%N/A0.106%
2/2/2021M&G Investment Management Ltd.176,619$3.61M0.0%+12.7%0.050%
2/2/2021BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp501,947$10.41M0.1%-14.8%0.141%
2/2/2021Parallel Advisors LLC1,951$41K0.0%+38.8%0.001%
2/1/2021Armstrong Henry H Associates Inc.65,525$1.36M0.2%-11.3%0.018%
Data available starting January 2016

See Full Table
Bausch Health Companies logo
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Read More

Today's Range

Now: $31.05

50 Day Range

MA: $27.46

52 Week Range

Now: $31.05


5,369,143 shs

Average Volume

4,579,465 shs

Market Capitalization

$11.03 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Bausch Health Companies?

Bausch Health Companies' top insider investors include:
  1. William D Humphries (Insider)
  2. Schutter Richard U De (Director)
  3. Christina Ackermann (EVP)
  4. Mark C Mckenna (Insider)
  5. Eschenbach Andrew C Von (Director)
  6. Holdings LP Valueact (Director)
  7. John Paulson (Director)
  8. Joseph C Papa (CEO)

Who are the major institutional investors of Bausch Health Companies?

Bausch Health Companies' top institutional shareholders include:
  1. Morgan Stanley — 2.12%
  2. Price T Rowe Associates Inc. MD — 1.65%
  3. Guardian Capital LP — 1.44%
  4. Icahn Carl C — 1.42%
  5. Laurion Capital Management LP — 1.14%
  6. Fiera Capital Corp — 0.95%

Which major investors are selling Bausch Health Companies stock?

Within the previous quarter, BHC stock was sold by these institutional investors:
  1. Price T Rowe Associates Inc. MD
  2. Renaissance Technologies LLC
  3. Wells Fargo & Company MN
  4. Sumitomo Mitsui Trust Holdings Inc.
  5. Healthcare of Ontario Pension Plan Trust Fund
  6. Eaton Vance Management
  7. Intact Investment Management Inc.
  8. Westpac Banking Corp

Which major investors are buying Bausch Health Companies stock?

Within the previous quarter, BHC stock was bought by institutional investors including:
  1. Icahn Carl C
  2. Laurion Capital Management LP
  3. Avidity Partners Management LP
  4. Guardian Capital LP
  5. Canada Pension Plan Investment Board
  6. Schroder Investment Management Group
  7. Ieq Capital LLC
  8. Fiera Capital Corp
During the last year, these company insiders have bought Bausch Health Companies stock:
  1. William D Humphries (Insider)
  2. Schutter Richard U De (Director)
  3. Christina Ackermann (EVP)
  4. Mark C Mckenna (Insider)
  5. Eschenbach Andrew C Von (Director)
  6. Holdings LP Valueact (Director)
  7. John Paulson (Director)
This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here